After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Catalyst Pharmaceuticals Inc (CPRX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.26, or -1.94%, to $13.12. The Catalyst Pharmaceuticals Inc has recorded 366,653 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $13.38 and fluctuated between $13.45 as its day high and $12.91 as its day low. The current market capitalization of Catalyst Pharmaceuticals Inc is $1.43B. A total of 1.79 million shares were traded on the day, compared to an average of 1.22M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CPRX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 44 BUYs and 34 SELLs from insiders. Insiders purchased 1,703,653 shares during that period but sold 1,249,003.
In the most recent transaction, MCENANY PATRICK J sold 26,151 shares of CPRX for 13.23 per share on May 15. After the transaction, the President and CEO now owns 3,945,436 company shares. In a previous transaction on Apr 05, Tierney David S sold 30,000 shares at 16.83 per share. CPRX shares that Director owns now total 313,541.
Among the insiders who sold shares, GRANDE ALICIA disposed of 50,000 shares on Mar 29 at a per-share price of $16.70. This resulted in the VP, Treasurer and CFO holding 50,557 shares of CPRX after the transaction. In another insider transaction, Del Carmen Jeffrey sold 40,000 shares at $16.70 per share on Mar 29. Company shares held by the Chief Commercial Officer now total 7,541.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CPRX in the last 3 months, the mean price target is $23.30 with high estimates of $27.00 and low estimates of $15.50. In terms of 52-week highs and lows, CPRX has a high of $22.11 and a low of $11.09.
As of this writing, CPRX has an earnings estimate of $0.28 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.32 per share and a lower estimate of $0.23. The company reported an EPS of $0.33 in the last quarter, which was -8.30% lower than expectations of $0.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CPRX’s latest balance sheet shows that the firm has $191.27M in Cash & Short Term Investments as of fiscal 2021. There were $3.89M in debt and $27.06M in liabilities at the time. Its Book Value Per Share was $3.27, while its Total Shareholder’s Equity was $206.83M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CPRX is Buy with a score of 4.60.
